Poland · Delayed Price · Currency is PLN Nestmedic Statistics
Total Valuation
Nestmedic has a market cap or net worth of PLN 35.37 million. The enterprise value is 35.41 million.
| Market Cap | 35.37M |
| Enterprise Value | 35.41M |
Important Dates
The next confirmed earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nestmedic has 55.43 million shares outstanding.
| Current Share Class | 55.43M |
| Shares Outstanding | 55.43M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.47% |
| Owned by Institutions (%) | 2.89% |
| Float | 22.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.73 |
| PB Ratio | 4.26 |
| P/TBV Ratio | 4.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.73 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.57 |
Financial Efficiency
Return on equity (ROE) is -76.90% and return on invested capital (ROIC) is -31.05%.
| Return on Equity (ROE) | -76.90% |
| Return on Assets (ROA) | -19.12% |
| Return on Invested Capital (ROIC) | -31.05% |
| Return on Capital Employed (ROCE) | -40.32% |
| Weighted Average Cost of Capital (WACC) | 5.92% |
| Revenue Per Employee | 339,413 |
| Profits Per Employee | -1.46M |
| Employee Count | 3 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.06 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.04% in the last 52 weeks. The beta is 0.24, so Nestmedic's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +44.04% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 52.24 |
| Average Volume (20 Days) | 33,957 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nestmedic had revenue of PLN 1.02 million and -4.37 million in losses.
| Revenue | 1.02M |
| Gross Profit | 813,410 |
| Operating Income | -4.08M |
| Pretax Income | -4.37M |
| Net Income | -4.37M |
| EBITDA | -3.13M |
| EBIT | -4.08M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.61 million in cash and 660,780 in debt, with a net cash position of 950,810 or 0.02 per share.
| Cash & Cash Equivalents | 1.61M |
| Total Debt | 660,780 |
| Net Cash | 950,810 |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 8.29M |
| Book Value Per Share | n/a |
| Working Capital | 3.91M |
Cash Flow
| Operating Cash Flow | -7.31M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 951,090 |
| Net Borrowing | 212,770 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 79.88% |
| Operating Margin | -400.31% |
| Pretax Margin | -429.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nestmedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -12.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |